|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: GLOBOCAN 2008 v1.2, Cancer Incidence and
Mortality Worldwide: IARC CancerBase No. 10. Lyon, France:
International Agency for Research on Cancer; 2010
|
|
2
|
Di Bisceglie AM: Issues in screening and
surveillance for hepatocellular carcinoma. Gastroenterology.
127:S104–S107. 2004.PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bushati N and Cohen SM: MicroRNAs
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar
|
|
5
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sayed D and Abdellatif M: MicroRNAs in
development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA and Croce CM: MicroRNAs
signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of PTEN
tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wong QW, Ching AK, Chan AW, Choy KW, To
KF, Lai PB and Wong N: MiR-222 overexprssion confers cell migratory
advantages in hepatocellular carcinoma through enhancing AKT
signaling. Clin Cancer Res. 16:867–875. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y and
Zheng X: MiR-34a inhibits migration and invasion by down-regulation
of c-Met expression in human hepatocellaular carcinoma cells.
Cancer Lett. 275:44–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salvi A, Sabelli C, Moncini S, Venturin M,
Arici B, Riva P, Portolani N, Giulini SM, De Petro G and Barlati S:
MicroRNA-23b mediates urokinase and c-met downmodulation and a
decreased migration of human hepatocellular carcinoma cells. FEBS
J. 276:2966–2982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW,
Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, et al: MicroRNA-122, a
tumor suppressor microRNA that regulates intrahepatic metastasis of
hepatocellular carcinoma. Hepatology. 49:1571–1582. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: MiR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Prueitt RL, Yi M, Hudson RS, Wallace TA,
Howe TM, Yfantis HG, Lee DH, Stephens RM, Liu CG, Calin GA, et al:
Expression of microRNAs and protein-coding genes associated with
perineural invasion in prostate cancer. Prostate. 68:1152–1164.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mees ST, Mardin WA, Sielker S, Willscher
E, Senninger N, Schleicher C, Colombo-Benkmann M and Haier J:
Involvement of CD40 targeting miR-224 and miR-486 on the
progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol.
16:2339–2350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arndt GM, Dossey L, Cullen LM, Lai A,
Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, et al:
Characterization of global microRNA expression reveals oncogenic
potential of miR-145 in metastatic colorectal cancer. BMC Cancer.
9:3742009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
White NM, Chow TF, Mejia-Guerrero S,
Diamandis M, Rofael Y, Faragalla H, Mankaruous M, Gabril M, Girgis
A and Yousef GM: Three dysregulated miRNAs control kallikrein 10
expression and cell proliferation in ovarian cancer. Br J Cancer.
102:1244–1253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boguslawska J, Wojcicka A,
Piekielko-Witkowska A, Master A and Nauman A: MiR-224 targets the
3′UTR of type 1 5′-iodothyronine deiodinase possibly contributing
to tissue hypothyroidism in renal cancer. PLoS One.
6:245412011.
|
|
20
|
Wang Y, Lee AT, Ma JZ, Wang J, Ren J, Yang
Y, Tantoso E, Li KB, Ooi LL, Tan P and Lee CG: Profiling microRNA
expression in hepatocellular carcinoma reveals microRNA-224
up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific
target. J Biol Chem. 283:13205–13215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Q, Wang G, Shan JL, Yang ZX, Wang HZ,
Feng J, Zhen JJ, Chen C, Zhang ZM, Xu W, et al: MicroRNA-224 is
upregulated in HepG2 cells and involved in cellular migration and
invasion. J Gastroenterol Hepatol. 25:164–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ory S, Zhou M, Conrads TP, Veenstra TD and
Morrison DK: Protein phosphatase 2A positively regulates Ras
signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3
binding sites. Curr Biol. 13:1356–1364. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Basu S: PP2A in the regulation of cell
motility and invasion. Curr Protein Pept Sci. 12:3–11. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hamano R, Miyata H, Yamasaki M, Kurokawa
Y, Hara J, Moon J, Nakajima K, Takiguchi S, Fujiwara Y, Mori M and
Doki Y: Overexpression of miR-200c induces chemoresistance in
esophageal cancers mediated through activation of the AKT signaling
pathway. Clin Cancer Res. 17:26032011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Inui M, Martello G and Piccolo S: MicroRNA
control of signal transduction. Nat Rev Mol Cell Biol.
11:2252–2262. 2010. View
Article : Google Scholar
|
|
26
|
Datta J, Kutay H, Nasser MW, Nuovo GJ,
Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, et
al: Methylation mediated silencing of microRNA-1 gene and its role
in hepatocellular carcinogenesis. Cancer Res. 68:5049–5058. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Garofalo M, Di Leva G, Romano G, Nuovo G,
Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P,
et al: miR-221 & 222 regulate TRAIL resistance and enhance
tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell.
16:498–509. 2009.
|
|
28
|
Wang B, Hsu SH, Majumder S, Kutay H, Huang
W, Jacob ST and Ghoshal K: TGFbeta-mediated upregulation of hepatic
miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Oncogene. 29:1787–1797. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wendel HG, De Stanchina E and Fridman JS:
Survival signalling by Akt and eIF4E in oncogenesis and cancer
therapy. Nature. 428:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
